Verona Pharma plc Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Verona Pharma plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q1 2025.
  • Verona Pharma plc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2025 was -$16.3M, a 36.7% increase year-over-year.
  • Verona Pharma plc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2025 was -$164M, a 159% decline year-over-year.
  • Verona Pharma plc annual Net Income (Loss) Attributable to Parent for 2024 was -$173M, a 219% decline from 2023.
  • Verona Pharma plc annual Net Income (Loss) Attributable to Parent for 2023 was -$54.4M, a 20.9% increase from 2022.
  • Verona Pharma plc annual Net Income (Loss) Attributable to Parent for 2022 was -$68.7M, a 23.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.